WeVote
Log In

Bill

Bill

A 4868

Eliminates use of vaccines containing mercury over three years.

2026-2027 Regular Session Introduced by Greg McGuckin

The bill would phase out and ban vaccines containing mercury in New Jersey within three years.

Introduced, Referred to Assembly Health Committee
0
WeVote Research Nonpartisan
Bill Summary · A 4868

Bill Summary: A-4868 (New Jersey, 2026) – Eliminates Use of Vaccines Containing Mercury Over Three Years

Overview

  • Jurisdiction: New Jersey
  • Session: 222
  • Title: Eliminates use of vaccines containing mercury over three years
  • Status: Introduced and referred to Assembly Health Committee on May 4, 2026
  • Sponsors: Primary sponsor not listed; Co-sponsor: Greg McGuckin

Purpose and Intent

The bill seeks to prohibit the use of vaccines containing mercury (specifically in the form of certain preservative compounds) and to implement a phased transition away from mercury-containing vaccines over a period of three years. The underlying aim is to reduce potential exposure to mercury-based components in vaccines administered within the state.

Key Provisions (expected/typical elements based on title and summarization)

Note: The following reflects the core concepts implied by the bill’s title and stated objective. The exact statutory language may specify details such as definitions, timelines, enforcement, and exemptions.

  • Prohibition on Mercury-Containing Vaccines: The bill would ban the use, administration, and distribution of vaccines that contain mercury-based preservatives or compounds (commonly ethylmercury in the form of thimerosal) within New Jersey.
  • Three-Year Phase-Out Timeline: The prohibition would be implemented gradually, with a complete ban effective by the end of a three-year period from enactment.
  • Affected Entities:
    • Government health agencies (state and local) administering vaccines
    • Licensed healthcare providers (physicians, nurses, pharmacists) administering vaccines
    • Hospitals, clinics, and other healthcare facilities that stock and administer vaccines
  • Preservative Standards: The bill may define acceptable preservative alternatives or require vaccines to be preservative-free or use non-mercury-based preservatives.
  • Vaccination Programs: Potential impact on state-funded vaccination programs, school-entry vaccination requirements, and eligible populations (e.g., children, adults, special populations).
  • Exemptions and Alternatives: Possible medical exemptions or waivers where mercury-containing vaccines are the only available option; potential use of non-mercury formulations where feasible.
  • Compliance and Enforcement: Provisions for monitoring, reporting, and enforcement, including penalties or corrective actions for noncompliance (e.g., fines, administrative actions).

Who Would Be Affected

  • Healthcare Providers and Facilities: Those who administer vaccines would need to ensure vaccines used comply with the mercury-free requirement.
  • Public Health Programs: State and local vaccination programs would align procurement and distribution with the mercury-free mandate.
  • Patients/Recipients: Individuals receiving vaccines could be affected in terms of vaccine choices, availability, and potential changes to vaccination schedules if mercury-free alternatives differ in formulation or supply.
  • Vaccine Manufacturers and Suppliers: Manufacturers supplying vaccines to the state would adjust product lines to meet the mercury-free requirement.

Procedural and Timeline Considerations

  • Introduction and Referral: The bill was introduced and referred to the Assembly Health Committee (May 4, 2026).
  • Potential Milestones (subject to legislative process):
    • Committee hearings and potential amendments
    • Passage by one or both houses (Assembly and Senate)
    • Gubernatorial action (signature or veto)
    • Implementation date corresponding to the three-year phase-out period

Additional Context

  • The bill’s focus aligns with public health and consumer safety concerns regarding mercury exposure in vaccines. If enacted, it would require coordination across state health departments, healthcare providers, and vaccine suppliers to ensure a steady transition to mercury-free formulations without disrupting vaccination coverage.

If you’d like, I can tailor this summary to include hypothetical fiscal impact, enforcement mechanisms, or compare it with existing NJ laws on vaccines and preservatives, once the bill’s full text is available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.